<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17990" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Atypical Fibroxanthoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kolb</surname>
            <given-names>Logan</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schmieder</surname>
            <given-names>George J.</given-names>
          </name>
          <aff>Orange Park</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Logan Kolb declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>George Schmieder declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>18</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17990.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Atypical fibroxanthoma (AFX) is a rare, low-grade superficial sarcoma that typically presents as a red nodule or plaque, most often on the head and neck of older adults, particularly in individuals who are White. This condition is considered a superficial variant of undifferentiated pleomorphic sarcoma, sharing similar histological features but with a less aggressive clinical course. AFX is usually found in sun-exposed areas and can also appear on the trunk, shoulders, upper extremities, and hands. Surgical excision is the preferred treatment for AFX, offering a high rate of cure, though recurrence is possible; metastasis, however, is uncommon.</p>
        <p>In this educational activity, the participant learns the pathophysiology, presentation, and management of atypical fibroxanthoma. Emphasis is placed on the importance of surgical excision and patient education, particularly regarding sun protection and regular skin examinations for early detection. Collaboration with an interprofessional team, including dermatologists, oncologists, pathologists, and surgeons, enhances patient outcomes by ensuring accurate diagnosis, effective treatment planning, and comprehensive follow-up care. This team-based approach reduces the risk of recurrence and improves the long-term management of AFX.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Implement appropriate surgical management techniques, ensuring complete excision of the lesion to reduce the risk of recurrence.</p></list-item><list-item><p>Assess the histopathological features of biopsied lesions to confirm the diagnosis of atypical fibroxanthoma.</p></list-item><list-item><p>Apply evidence-based guidelines for post-surgical care and follow-up, monitoring for any signs of recurrence or complications.</p></list-item><list-item><p>Communicate&#x000a0;the interprofessional team strategies for improving care coordination regarding managing patients with atypical fibroxanthoma.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17990&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17990">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17990.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Atypical fibroxanthoma is a rare, low-grade superficial sarcoma frequently presenting as a red nodule or plaque. This condition is a superficial variant of undifferentiated pleomorphic sarcoma (formerly malignant fibrous histiocytoma). Although atypical fibroxanthoma&#x000a0;has similar histologic features to undifferentiated pleomorphic sarcoma, it behaves less aggressively.<xref ref-type="bibr" rid="article-17990.r1">[1]</xref><xref ref-type="bibr" rid="article-17990.r2">[2]</xref><xref ref-type="bibr" rid="article-17990.r3">[3]</xref><xref ref-type="bibr" rid="article-17990.r4">[4]</xref></p>
      </sec>
      <sec id="article-17990.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of atypical fibroxanthomas is poorly understood. Researchers believe it arises from myofibroblasts or fibroblast-like cells. Ultraviolet light appears to play a significant role since most lesions appear on the sun-exposed head and neck of White individuals. Genetic factors also contribute to the development of atypical&#x000a0;fibroxanthoma since it shares genetic alterations with undifferentiated pleomorphic sarcomas, including chromosome 9p and 13q deletions. However, undifferentiated pleomorphic sarcoma&#x000a0;has a statistically significant larger amount of genomic alterations and a more aggressive clinical course. Other possible risk factors for atypical&#x000a0;fibroxanthoma&#x000a0;include trauma to the skin, radiation therapy, and immunosuppression (eg, diabetes, human immunodeficiency virus, organ transplant).<xref ref-type="bibr" rid="article-17990.r5">[5]</xref><xref ref-type="bibr" rid="article-17990.r6">[6]</xref><xref ref-type="bibr" rid="article-17990.r7">[7]</xref><xref ref-type="bibr" rid="article-17990.r8">[8]</xref></p>
      </sec>
      <sec id="article-17990.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Atypical fibroxanthomas are most commonly seen on the head and neck of&#x000a0;older White individuals. Other reported sites of atypical fibroxanthoma include the trunk, shoulders, upper extremities, and dorsum of the hands. Trunk and limb lesions appear more commonly in younger patients (mean age 39) than head and neck lesions in the elderly (mean age 69). Results from a review of 171 cases in Western Australia found a patient age range of 41 to 97 years old (median age 74), with 76% of the tumors occurring in men. Atypical&#x000a0;fibroxanthoma has also been reported in patients as young as 13&#x000a0;with predisposing disorders such as Li-Fraumeni syndrome and xeroderma pigmentosum. The incidence increases in immunosuppressed populations, with an estimated 78 per 100,000 patients with a transplantation.</p>
      </sec>
      <sec id="article-17990.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of atypical fibroxanthomas is poorly characterized. Ultra-violet (UV) light has implications for its pathogenesis due to atypical&#x000a0;fibroxanthoma&#x000a0;predilection for sun-exposed areas of the body and the presence of atypical&#x000a0;fibroxanthoma in xeroderma pigmentosum patients who exhibit defective repair of UV-induced cyclobutane pyrimidine dimers. Research results have documented these UV-induced pyrimidine dimers in atypical&#x000a0;fibroxanthoma&#x000a0;lesions and mutations in the tumor suppressor gene p53. Various rare genetic disorders have correlations with p53-induced atypical fibroxanthomas, including Li-Fraumeni syndrome (with germline p53 mutations) and xeroderma pigmentosum. One study's results showed that mutations of <italic toggle="yes">H-Ras</italic> and <italic toggle="yes">K-Ras</italic> genes were present in malignant fibrous histiocytoma&#x000a0;but not in atypical&#x000a0;fibroxanthoma&#x000a0;lesions; this research may prove helpful in establishing the diagnosis of atypical&#x000a0;fibroxanthoma.</p>
      </sec>
      <sec id="article-17990.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Hematoxylin and eosin stains of atypical&#x000a0;fibroxanthoma&#x000a0;lesions show a dermally-based tumor with pleomorphism, atypical mitotic figures, and a spindly architecture. Atypical&#x000a0;fibroxanthoma&#x000a0;lesions occasionally extend to the subcutaneous tissue. Note that atypical&#x000a0;fibroxanthoma&#x000a0;is a dermal-based process, while spindle cell squamous cell carcinoma variants (on the differential diagnosis) connect with the epidermis and show signs of keratinization. Multinucleated giant cells and solar elastosis are often present in atypical&#x000a0;fibroxanthoma&#x000a0;biopsy specimens, while a mixed inflammatory infiltrate may be found at the edge of the tumor. Immunohistochemistry is required to rule out other neoplasms, including spindloid&#x000a0;squamous cell carcinoma, melanoma, and undifferentiated pleomorphic sarcoma.</p>
        <p>Since atypical fibroxanthoma stains are positive for several non-specific stains, including a cluster of differentiation 10 (CD10), p53, S100A6, vimentin, and procollagen-1, it is considered a diagnosis of exclusion histologically. Of note, atypical&#x000a0;fibroxanthoma&#x000a0;stains negative for HMB-45, p40 (often positive in squamous cell carcinoma), desmin, pan-cytokeratin stains, CD31, and has sparse staining for S100, which may help differentiate it from melanoma. Since poorly differentiated sarcomatoid carcinomas may lose cytokeratin expression, various cytokeratin stains should be used. Severe variants of atypical&#x000a0;fibroxanthoma&#x000a0;have been described based on various histologic findings, including pigmented atypical&#x000a0;fibroxanthoma&#x000a0;due to hemosiderin deposit and not actual melanin pigment, granular cell atypical&#x000a0;fibroxanthoma, sclerotic atypical&#x000a0;fibroxanthoma, spindle cell nonpleomorphic atypical&#x000a0;fibroxanthoma, osteoid atypical&#x000a0;fibroxanthoma, chondroid atypical&#x000a0;fibroxanthoma, myxoid atypical&#x000a0;fibroxanthoma, keloidal atypical&#x000a0;fibroxanthoma, osteoclast-like giant-cell rich atypical&#x000a0;fibroxanthoma, and clear cell atypical&#x000a0;fibroxanthoma.</p>
      </sec>
      <sec id="article-17990.s7" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>While there is no direct association to date, researchers&#x000a0;hypothesize&#x000a0;that arsenic exposure may predispose patients to atypical&#x000a0;fibroxanthoma.</p>
      </sec>
      <sec id="article-17990.s8" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Atypical fibroxanthomas present as well-circumscribed red or pink nodules or plaque that may have ulceration, crust, or scale. Atypical&#x000a0;fibroxanthoma&#x000a0;lesions are typically small in size, with a median diameter of 1 cm, with less than 5% of the&#x000a0;lesions being greater than 2 cm in diameter. They often develop rapidly but lack symptoms such as pain or pruritus. More than 90% of atypical&#x000a0;fibroxanthoma&#x000a0;tumors occur on the head and neck, while the remaining cases typically present on the extremities and trunk. Dermoscopy of lesions reveals polymorphic vessels (linear, dotted, hairpin, arborescent, and/or highly tortuous vessels) radiating to the center of the lesion with intervening white areas. The differential diagnosis includes basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, amelanotic melanoma, leiomyosarcoma, atypical (pseudosarcomatous) dermatofibroma, pleomorphic dermal sarcomas, and metastasis from internal malignancies. Compared to atypical&#x000a0;fibroxanthoma,&#x000a0;pleomorphic dermal sarcomas&#x000a0;are&#x000a0;often&#x000a0;clinically&#x000a0;larger and are more likely to recur locally and metastasize.</p>
      </sec>
      <sec id="article-17990.s9" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A skin biopsy is the diagnostic gold standard for atypical&#x000a0;fibroxanthoma, a rare condition that clinically mimics basal and squamous cell carcinomas, Merkel cell carcinomas, and amelanotic melanomas. Immunohistochemistry is a common test used to make the diagnosis (see "histopathology" above). When atypical&#x000a0;fibroxanthoma&#x000a0;lesions have metastasized or are poorly accessible (eg, subungual lesions), magnetic resonance imaging (MRI) may be helpful. MRI shows intermediate T1 and T2-weighted signal intensity compared to the high signal intensity of squamous cell carcinoma and melanoma.</p>
      </sec>
      <sec id="article-17990.s10" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Fortunately, atypical&#x000a0;fibroxanthoma&#x000a0;rarely metastasizes and recurs in only 6% to 10% of cases. Risk factors for metastases include immunocompromised state, tumor depth, vascular or perineural invasion, and the presence of tumor necrosis. The most commonly reported locations for metastases include the parotid gland, lymph nodes, and subcutaneous tissue. Metastases, when present, are typically evident 12 to 24 months after the initial diagnosis of atypical&#x000a0;fibroxanthoma. The treatment of choice for atypical&#x000a0;fibroxanthoma&#x000a0;is surgical excision.&#x000a0;Previously, this utilized 1 cm margins, however Mohs micrographic surgery and regular follow-up have become the standard of care, with recurrence rates reported at 0.0% to 6.9%. In patients who are poor surgical candidates, electronic brachytherapy&#x000a0;has successfully treated atypical&#x000a0;fibroxanthoma&#x000a0;and is even more effective if there is tumor debulking before therapy. Another reported treatment modality is electrodesiccation and curettage, which may be appropriate for slow-growing lesions less than 1 cm&#x000a0;in diameter.</p>
      </sec>
      <sec id="article-17990.s11" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses for atypical fibroxanthoma<bold>&#x000a0;</bold>include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Amelanotic melanoma</p>
          </list-item>
          <list-item>
            <p>Atypical fibroxanthoma</p>
          </list-item>
          <list-item>
            <p>Basal cell carcinoma</p>
          </list-item>
          <list-item>
            <p>Dermatofibroma with monster cell</p>
          </list-item>
          <list-item>
            <p>Leiomyosarcoma</p>
          </list-item>
          <list-item>
            <p>Undifferentiated pleomorphic sarcoma</p>
          </list-item>
          <list-item>
            <p>Melanoma</p>
          </list-item>
          <list-item>
            <p>Merkel cell carcinoma</p>
          </list-item>
          <list-item>
            <p>Neurothekeoma</p>
          </list-item>
          <list-item>
            <p>Pleomorphic dermal</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17990.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Atypical fibroxanthoma&#x000a0;rates&#x000a0;a low-grade sarcoma, usually occurring on sun-exposed head and neck areas in older adult patients. The prognosis is generally excellent when treated with adequate primary tumor excision; recurrence of the tumor occurs in approximately 5% of cases.<xref ref-type="bibr" rid="article-17990.r9">[9]</xref><xref ref-type="bibr" rid="article-17990.r7">[7]</xref><xref ref-type="bibr" rid="article-17990.r10">[10]</xref></p>
      </sec>
      <sec id="article-17990.s13" sec-type="Complications">
        <title>Complications</title>
        <p>When promptly addressed and treated through adequate excision, atypical fibroxanthoma seldom causes complications. This condition can exhibit significant sclerosis in some instances.<xref ref-type="bibr" rid="article-17990.r11">[11]</xref> There have also been some cases of metastatic involvement, although rare.<xref ref-type="bibr" rid="article-17990.r12">[12]</xref></p>
      </sec>
      <sec id="article-17990.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Prevention of atypical fibroxanthoma is centered around UV protection and yearly full-body skin exams for early detection.</p>
      </sec>
      <sec id="article-17990.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Healthcare professionals may frequently encounter abnormal skin growth in patients. Because the differential of dermal growths is large, these patients require a referral to a dermatologist or plastic surgeon for a definitive diagnosis. Atypical fibroxanthoma is&#x000a0;1 such growth that often presents in those who are older and White. Risk factors for metastases include immunocompromised state, tumor depth, vascular or perineural invasion, and the presence of tumor necrosis. The most commonly reported locations for metastases include the parotid gland, lymph nodes, and subcutaneous tissue. The treatment of choice for atypical&#x000a0;fibroxanthoma&#x000a0;is surgical excision. The key is to educate the patient on avoiding sun exposure and getting regular physical exams for early detection. Recurrence can occur, but metastatic spread is rare.<xref ref-type="bibr" rid="article-17990.r12">[12]</xref><xref ref-type="bibr" rid="article-17990.r13">[13]</xref></p>
      </sec>
      <sec id="article-17990.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17990&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17990">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/atypical-fibroxanthoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17990">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17990/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17990">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17990.s17">
        <title>References</title>
        <ref id="article-17990.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Merati</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bordeaux</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Atypical Fibroxanthoma Invading Parietal Bone.</article-title>
            <source>Dermatol Surg</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>44</volume>
            <issue>12</issue>
            <fpage>1644</fpage>
            <page-range>1644-1646</page-range>
            <pub-id pub-id-type="pmid">30481164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klebanov</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hoang</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>BY</given-names>
              </name>
            </person-group>
            <article-title>Pleomorphic Dermal Sarcoma of the Scalp.</article-title>
            <source>Cureus</source>
            <year>2018</year>
            <month>Jul</month>
            <day>13</day>
            <volume>10</volume>
            <issue>7</issue>
            <fpage>e2979</fpage>
            <pub-id pub-id-type="pmid">30237940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fix</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Khanna</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lewin</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Atypical Fibroxanthoma Arising in a Burn Scar Treated With Mohs Micrographic Surgery.</article-title>
            <source>Dermatol Surg</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>44</volume>
            <issue>9</issue>
            <fpage>1229</fpage>
            <page-range>1229-1231</page-range>
            <pub-id pub-id-type="pmid">30141777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giorgini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barbaccia</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Croci</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Imarisio</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Vassallo</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Rapid development of atypical fibroxanthoma during vismodegib treatment.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-88</page-range>
            <pub-id pub-id-type="pmid">30132948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tolkachjov</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Kelley</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Alahdab</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Brewer</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>79</volume>
            <issue>5</issue>
            <fpage>929</fpage>
            <page-range>929-934.e6</page-range>
            <pub-id pub-id-type="pmid">29981390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Worley</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nemechek</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Stoler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Naturopathic Self-Treatment of an Atypical Fibroxanthoma: Lessons for Dermatologic Surgery.</article-title>
            <source>J Drugs Dermatol</source>
            <year>2018</year>
            <month>Jun</month>
            <day>01</day>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>683</fpage>
            <page-range>683-685</page-range>
            <pub-id pub-id-type="pmid">29879257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winchester</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lehman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tello</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chimato</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hocker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Markey</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yom</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mully</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hodge</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Otley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arron</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>79</volume>
            <issue>5</issue>
            <fpage>853</fpage>
            <page-range>853-859</page-range>
            <pub-id pub-id-type="pmid">29787841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moscarella</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Piana</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Specchio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kyrgidis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nazzaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Eliceche</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Savoia</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bugatti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Filosa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zalaudek</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Scarfi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Inskip</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rosendahl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pyne</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Siggs</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>To&#x0011f;ral</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Cabo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Drlik</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lallas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Argenziano</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopy features of atypical fibroxanthoma: A multicenter study of the International Dermoscopy Society.</article-title>
            <source>Australas J Dermatol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>309</fpage>
            <page-range>309-314</page-range>
            <pub-id pub-id-type="pmid">29569417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bitel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;nlebe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kr&#x000f6;nert</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wollina</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Atypical fibroxanthoma: An analysis of 105 tumors.</article-title>
            <source>Dermatol Ther</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>e13962</fpage>
            <pub-id pub-id-type="pmid">32618393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirza</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Weedon</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Atypical fibroxanthoma: a clinicopathological study of 89 cases.</article-title>
            <source>Australas J Dermatol</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>235</fpage>
            <page-range>235-8</page-range>
            <pub-id pub-id-type="pmid">16197421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruecks</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Medlicott</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Trotter</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Atypical fibroxanthoma with prominent sclerosis.</article-title>
            <source>J Cutan Pathol</source>
            <year>2003</year>
            <month>May</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>336</fpage>
            <page-range>336-9</page-range>
            <pub-id pub-id-type="pmid">12753176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Torres-Cabala</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Curry</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ivan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McLemore</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tetzlaff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zembowicz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Prieto</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Lazar</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Metastatic atypical fibroxanthoma: a series of 11 cases including with minimal and no subcutaneous involvement.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>455</fpage>
            <page-range>455-61</page-range>
            <pub-id pub-id-type="pmid">25590287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17990.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nonaka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bishop</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>Sarcoma-like tumor of head and neck skin.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>7</issue>
            <fpage>956</fpage>
            <page-range>956-65</page-range>
            <pub-id pub-id-type="pmid">24705313</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
